Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Mederi Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Mederi Therapeutics

Mederi Therapeutics

Public

Mederi Therapeutics: Manufacturing RF energy-based medical devices for digestive health.

HQ
Greenwich, CT, US
Founded
2008
Overview
Compare
Fundraising
Employees

Mederi Therapeutics manufactures medical devices that deliver radio

frequency energy to treat diseases affecting the human digestive system.

Mederi Therapeutics - Similar Companies

Medicreations logo

Medicreations

medicreations.com

Merit Medical Systems logo

Merit Medical Systems

merit.com

Medtor logo

Medtor

medtorllc.com

Medical Device Innovations logo

Medical Device Innovations

Thermedical logo

Thermedical

thermedical.com

Mirabilis Medica logo

Mirabilis Medica

Mercury Biomed logo

Mercury Biomed

Jan Medical logo

Jan Medical

janmedical.com

Advanced Medical Device Technologies logo

Advanced Medical Device Technologies

advancedmdt.com

Medical Technologies Innovation Asia logo

Medical Technologies Innovation Asia

Infused Medical Technology logo

Infused Medical Technology

Mercator Medsystems logo

Mercator Medsystems

mercatormed.com

Nemedio logo

Nemedio

nemedio.com

Max Endoscopy logo

Max Endoscopy

maxendoscopy.com

MediBeacon logo

MediBeacon

medibeacon.com

Mederi Therapeutics - Quick Facts

Who are Mederi Therapeutics' competitors?

Companies similar to Mederi Therapeutics include Medicreations, Merit Medical Systems, Medtor and Medical Device Innovations.

When was Mederi Therapeutics founded?

Mederi Therapeutics was founded in 2008.

Where is Mederi Therapeutics' headquarters located?

Mederi Therapeutics' headquarters is located in Greenwich, CT, US.

When was Mederi Therapeutics' last funding round?

Mederi Therapeutics' most recent funding round was for $8.5M (USD) in December 2013.

How much has Mederi Therapeutics raised to-date?

As of Dec 23, 2013, Mederi Therapeutics has raised a total of $18.5M (USD).

How many employees does Mederi Therapeutics have?

Mederi Therapeutics has 30 employees as of Feb 4, 2024.

Mederi Therapeutics - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • RF Energy
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Consumers
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 8690Other human health activities
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 621000Ambulatory Health Care Services
  • 621600Home Health Care Services
  • 621610Home Health Care Services
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 8080Home Health Care Services
  • 8082Home Health Care Services
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies